Back to 
Centiva Capital, LP
Centiva Capital, LP
TVTX
Showing 0 of 2 quarters
Position history for Centiva Capital, LP's holdings in Travere Therapeutics, Inc.
No. Centiva Capital exited its TVTX (Travere Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 34,041 shares worth $304,327. Centiva Capital first reported TVTX in Q3 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.